Grant: Master's Award: Canada Graduate Scholarships
McGill University
$17,500.00
Investigating the role of inteferon gamma receptor 1 in ependymal cell pathology relating to MS
EF 2022-23
Résumé
Multiple sclerosis (or MS) is a highly debilitating disease characterized by the degeneration of myelin, an insulating fat layer that wraps around neurons in the brain and spinal cord. However, the exact origins of what leads to the development of MS are to this day poorly characterized. The brain and spinal cord are constantly immersed in cerebrospinal fluid (or CSF), which contains nutrients and immune factors. Proper circulation of this fluid has been shown to be dysregulated in early MS and lesions tend to form next to the CSF, such as in the periventricular area. Ependymal cells are a type of ciliated cells which line the ventricular system, forming a barrier and helping move CSF, and they have been found to be disrupted in this disease. The goal of this project is to address how CSF-derived cytotoxic immune factors can cause ependymal cell damage and subsequent CSF circulation disruption. Previous data in our lab has put forward interferon-gamma receptor 1 as of interest specifically in ependymal cell pathology related to MS. Using a specific genetic manipulation, we can conditionally remove interferon-gamma receptor 1 from ependymal cells in mice. By utilizing this manipulation combined with an established murine model of MS, we will be able to compare outcomes between mice with and without receptor presence in ependymal cells. More specifically, we will look at clinical outcomes, cellular pathology, levels of CSF flow, and ependymal barrier integrity. Altogether, this will allow us to better understand the effects of the pathways regulated by interferon-gamma in ependymal cells. In turn, this could provide possible directions for further research which could lead to the development of better treatments for MS.
Programme
Master's Award: Canada Graduate Scholarships
Bénéficiaire
Emplacement
Quebec, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database
Tel que publié
Id
498207
Name
Afanasiev Elia
Region
Québec
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Investigating the role of inteferon gamma receptor 1 in ependymal cell pathology relating to MS
Programtype2
Studentship Programs
Orgnameinp2
McGill University
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Cerebrospinal Fluid; Ependymagliosis; Ependymocytes; Glia; Gliosis; Interferon-Gamma; Multiple Sclerosis; Neuroimmunology; Neuroinflammation; Waste Clearance
Abstract
Multiple sclerosis (or MS) is a highly debilitating disease characterized by the degeneration of myelin, an insulating fat layer that wraps around neurons in the brain and spinal cord. However, the exact origins of what leads to the development of MS are to this day poorly characterized. The brain and spinal cord are constantly immersed in cerebrospinal fluid (or CSF), which contains nutrients and immune factors. Proper circulation of this fluid has been shown to be dysregulated in early MS and lesions tend to form next to the CSF, such as in the periventricular area. Ependymal cells are a type of ciliated cells which line the ventricular system, forming a barrier and helping move CSF, and they have been found to be disrupted in this disease. The goal of this project is to address how CSF-derived cytotoxic immune factors can cause ependymal cell damage and subsequent CSF circulation disruption. Previous data in our lab has put forward interferon-gamma receptor 1 as of interest specifically in ependymal cell pathology related to MS. Using a specific genetic manipulation, we can conditionally remove interferon-gamma receptor 1 from ependymal cells in mice. By utilizing this manipulation combined with an established murine model of MS, we will be able to compare outcomes between mice with and without receptor presence in ependymal cells. More specifically, we will look at clinical outcomes, cellular pathology, levels of CSF flow, and ependymal barrier integrity. Altogether, this will allow us to better understand the effects of the pathways regulated by interferon-gamma in ependymal cells. In turn, this could provide possible directions for further research which could lead to the development of better treatments for MS.
Competitiondate
202212
Approvedterm2
1 yr 0 mth
Pinamesdelim
Afanasiev, Elia
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~